USPTO trademark

NEOMAB BIO

RegisteredUSPTOWord markClass 42

"NEOMAB BIO" is a word mark owned by GemPharmatech Co., Ltd., filed at the USPTO on February 6, 2024. It is registered and covers class 42 (Computer and Scientific Services).

Official USPTO record
NEOMAB BIO trademark as filed
As filed with the USPTO
Status
Registered
Since August 19, 2025
Filed
February 6, 2024
Registered
August 19, 2025
Priority date
December 27, 2023
Claimed from China
Application no.
98394125
Registration no.
7896288
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns NEOMAB BIO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

Nanjing, Jiangsu, China

31 trademarks in the portfolioView company

Representative

Nazly Aileen Bayramoglu

Bayramoglu Law Offices LLC

Goods and services

What the mark covers

The products and services NEOMAB BIO is filed for, grouped by Nice class.

  • Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Assigned to lie
  10. Teas response to suspension inquiry received

10 earlier steps on the official record.

FAQ

About NEOMAB BIO

Who owns the trademark "NEOMAB BIO"?

The USPTO trademark "NEOMAB BIO" (application 98394125) is owned by GemPharmatech Co., Ltd.

What is the status of "NEOMAB BIO"?

Its status at the USPTO is: registered.

When was "NEOMAB BIO" registered?

It was registered on August 19, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NEOMAB BIO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2c93-00b6-74ed-8145-40b11009d43b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c93-00b6-74ed-8145-40b11009d43b",
  "object": "trademark",
  "mark_text": "NEOMAB BIO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98394125",
  "filing_date": "2024-02-06",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}